Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains.

Millan DS, Kayser-Bricker KJ, Martin MW, Talbot AC, Schiller SER, Herbertz T, Williams GL, Luke GP, Hubbs S, Alvarez Morales MA, Cardillo D, Troccolo P, Mendes RL, McKinnon C.

ACS Med Chem Lett. 2017 Jul 14;8(8):847-852. doi: 10.1021/acsmedchemlett.7b00191. eCollection 2017 Aug 10.

2.

Spectroscopic Photoacoustic Imaging of Gold Nanorods.

Namen AV, Luke GP.

Methods Mol Biol. 2017;1570:179-194. doi: 10.1007/978-1-4939-6840-4_12.

PMID:
28238137
3.

Blinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging.

Hannah AS, Luke GP, Emelianov SY.

Theranostics. 2016 Jul 25;6(11):1866-76. doi: 10.7150/thno.14961. eCollection 2016.

4.

Super-Resolution Ultrasound Imaging in Vivo with Transient Laser-Activated Nanodroplets.

Luke GP, Hannah AS, Emelianov SY.

Nano Lett. 2016 Apr 13;16(4):2556-9. doi: 10.1021/acs.nanolett.6b00108. Epub 2016 Apr 5.

5.

Label-free Detection of Lymph Node Metastases with US-guided Functional Photoacoustic Imaging.

Luke GP, Emelianov SY.

Radiology. 2015 Nov;277(2):435-42. doi: 10.1148/radiol.2015141909. Epub 2015 May 21.

6.

Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors.

Luke GP, Myers JN, Emelianov SY, Sokolov KV.

Cancer Res. 2014 Oct 1;74(19):5397-408. doi: 10.1158/0008-5472.CAN-14-0796. Epub 2014 Aug 8.

7.

In-vivo ultrasound and photoacoustic image- guided photothermal cancer therapy using silica-coated gold nanorods.

Kim S, Chen YS, Luke GP, Emelianov SY.

IEEE Trans Ultrason Ferroelectr Freq Control. 2014 May;61(5):891-7. doi: 10.1109/TUFFC.2014.6805702.

PMID:
24801630
8.

Optimization of in vivo spectroscopic photoacoustic imaging by smart optical wavelength selection.

Luke GP, Emelianov SY.

Opt Lett. 2014 Apr 1;39(7):2214-7. doi: 10.1364/OL.39.002214.

9.

Silica-coated gold nanoplates as stable photoacoustic contrast agents for sentinel lymph node imaging.

Luke GP, Bashyam A, Homan KA, Makhija S, Chen YS, Emelianov SY.

Nanotechnology. 2013 Nov 15;24(45):455101. doi: 10.1088/0957-4484/24/45/455101. Epub 2013 Oct 11.

10.

PHOTOACOUSTIC IMAGING FOR MEDICAL DIAGNOSTICS.

Bayer CL, Luke GP, Emelianov SY.

Acoust Today. 2012 Oct 1;8(4):15-23. No abstract available.

11.

Optical wavelength selection for improved spectroscopic photoacoustic imaging.

Luke GP, Nam SY, Emelianov SY.

Photoacoustics. 2013 Aug 28;1(2):36-42. doi: 10.1016/j.pacs.2013.08.001. eCollection 2013 May.

12.

Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging.

Homan KA, Souza M, Truby R, Luke GP, Green C, Vreeland E, Emelianov S.

ACS Nano. 2012 Jan 24;6(1):641-50. doi: 10.1021/nn204100n. Epub 2012 Jan 6.

13.

Biomedical applications of photoacoustic imaging with exogenous contrast agents.

Luke GP, Yeager D, Emelianov SY.

Ann Biomed Eng. 2012 Feb;40(2):422-37. doi: 10.1007/s10439-011-0449-4. Epub 2011 Nov 3. Review.

PMID:
22048668
14.

In vivo three-dimensional spectroscopic photoacoustic imaging for monitoring nanoparticle delivery.

Kim S, Chen YS, Luke GP, Emelianov SY.

Biomed Opt Express. 2011 Sep 1;2(9):2540-50. doi: 10.1364/BOE.2.002540. Epub 2011 Aug 5.

15.

Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance.

Mallidi S, Luke GP, Emelianov S.

Trends Biotechnol. 2011 May;29(5):213-21. doi: 10.1016/j.tibtech.2011.01.006. Epub 2011 Feb 15. Review.

16.

Software model of an improved bio-inspired sensor - biomed 2009.

Luke GP, Wright CH, Barrett SF.

Biomed Sci Instrum. 2009;45:179-84.

PMID:
19369760
17.

An efficient preparation of beta-aryl-beta-ketophosphonates by the TFAA/H3PO4-mediated acylation of arenes with phosphonoacetic acids.

Luke GP, Seekamp CK, Wang ZQ, Chenard BL.

J Org Chem. 2008 Aug 15;73(16):6397-400. doi: 10.1021/jo800973e. Epub 2008 Jul 22.

PMID:
18642870
18.

Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents.

Vu CB, Luke GP, Kawahata N, Shakespeare WC, Wang Y, Sundaramoorthi R, Metcalf CA 3rd, Keenan TP, Pradeepan S, Corpuz E, Merry T, Bohacek RS, Dalgarno DC, Narula SS, van Schravendijk MR, Ram MK, Adams S, Liou S, Keats JA, Violette SM, Guan W, Weigele M, Sawyer TK.

Bioorg Med Chem Lett. 2003 Sep 15;13(18):3071-4.

PMID:
12941336
19.

A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.

Kawahata N, Yang MG, Luke GP, Shakespeare WC, Sundaramoorthi R, Wang Y, Johnson D, Merry T, Violette S, Guan W, Bartlett C, Smith J, Hatada M, Lu X, Dalgarno DC, Eyermann CJ, Bohacek RS, Sawyer TK.

Bioorg Med Chem Lett. 2001 Sep 3;11(17):2319-23.

PMID:
11527723
20.

Structure-based design of novel bicyclic nonpeptide inhibitors for the src SH2 domain.

Shakespeare WC, Bohacek RS, Azimioara MD, Macek KJ, Luke GP, Dalgarno DC, Hatada MH, Lu X, Violette SM, Bartlett C, Sawyer TK.

J Med Chem. 2000 Oct 19;43(21):3815-9. No abstract available.

PMID:
11052784

Supplemental Content

Loading ...
Support Center